CN Patent

CN112239433B — 一种环己烷衍生物、制备方法及其应用

Assigned to Beijing Increase Innovative Drug Co ltd · Expires 2024-05-14 · 2y expired

What this patent protects

本发明属于化学药物领域，具体提供了一种环己烷衍生物或其立体异构体、药学上可接受的盐及其制备方法与应用。所述环己烷衍生物可用于治疗或预防需要调节多巴胺D2、D3和/或5HT‑2受体的病症。且本发明制备方法采用低廉易得的化工产品作为起始原料，且每步合成产率均较高，因此，生产成本较低。

USPTO Abstract

本发明属于化学药物领域，具体提供了一种环己烷衍生物或其立体异构体、药学上可接受的盐及其制备方法与应用。所述环己烷衍生物可用于治疗或预防需要调节多巴胺D2、D3和/或5HT‑2受体的病症。且本发明制备方法采用低廉易得的化工产品作为起始原料，且每步合成产率均较高，因此，生产成本较低。

Drugs covered by this patent

cariprazine-hydrochloride (CARIPRAZINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN112239433B
Jurisdiction: CN
Classification: —
Expires: 2024-05-14
Drug substance claim: No
Drug product claim: No
Assignee: Beijing Increase Innovative Drug Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.